BioNTech SE (BNTX) EBT Margin (2018 - 2025)
BioNTech SE's (BNTX) quarterly EBT Margin came in at 25.06% in Q4 2025, down 2507.0% year-on-year from 1.04% in Q4 2024, and down 1641.08% quarter-over-quarter from 1.63% in Q3 2025.
BioNTech SE (BNTX) EBT Margin (2018 - 2025) Analysis & Trends
BioNTech SE has disclosed EBT Margin across 8 years of filings, most recently posting 25.06% for Q4 2025.
- EBT Margin for Q4 2025 came in at 25.06%, down 2507.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 40.49% (down 4047.0% YoY), and the FY2025 annual result was 1399.2%, down 137457.0% from the prior year.
- EBT Margin came in at 25.06% for Q4 2025 at BioNTech SE, down from 1.63% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 85.2% in Q4 2021 to a low of 5162.82% in Q2 2025.
- The 5-year median for EBT Margin is 35.12% (2023), against an average of 541.61%.
- Peak annual rise in EBT Margin reached 168669 bps in 2025, while the deepest fall reached 453671 bps in 2025.
- BioNTech SE's EBT Margin stood at 85.2% in 2021, then decreased by 13 bps to 74.16% in 2022, then tumbled by 40 bps to 44.84% in 2023, then slumped by 100 bps to 0.01% in 2024, then sank by 274668 bps to 25.06% in 2025.
- The last three EBT Margin figures came in at 25.06% (Q4 2025), 1.63% (Q3 2025), and 5162.82% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 6.40% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 41.95% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | BioNTech SE | 27.38 Bn | 10.07 Bn | 668.28 Mn | -25.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -25.06% |
| Sep 30, 2025 | 1.63% |
| Jun 30, 2025 | -5,162.82% |
| Mar 31, 2025 | -1,919.83% |
| Dec 31, 2024 | 0.01% |
| Sep 30, 2024 | 12.75% |
| Jun 30, 2024 | -626.11% |
| Mar 31, 2024 | -3,606.52% |
| Dec 31, 2023 | 44.84% |
| Sep 30, 2023 | 25.40% |
| Jun 30, 2023 | -245.80% |
| Mar 31, 2023 | 55.42% |
| Dec 31, 2022 | 74.16% |
| Sep 30, 2022 | 70.61% |
| Jun 30, 2022 | 72.56% |
| Mar 31, 2022 | 78.72% |
| Dec 31, 2021 | 85.20% |
| Sep 30, 2021 | 76.67% |
| Jun 30, 2021 | 75.78% |
| Mar 31, 2021 | 80.17% |